Cognitive Deficits Completed Phase 4 Trials for Lorazepam (DB00186)

Back to Cognitive Deficits

Also known as: Cognitive Decline / Cognitive Deficit / Cognitive Dysfunction / Impaired cognition (finding) / Cognitive impairment / Cognitive disturbance / Cognitive function abnormal

IndicationStatusPhase
DBCOND0044823 (Cognitive Deficits)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01889602Characterizing and Predicting Drug Effects on CognitionOther